Eli Lilly’s CEO is ‘disappointed’ that only 1 in 10 Americans are on GLP-1s

Eli Lilly’s CEO is ‘disappointed’ that only 1 in 10 Americans are on GLP-1s

Eli Lilly CEO David Ricks is “disappointed” that only one in 10 Americans are on GLP-1s.The company, which is rolling out weight-loss pills designed to make the drugs more accessible to a larger part of the population, wants more people to add the drugs to their normal routines.“We look at that as disappointing on the one hand because our job is to get medicines to patients, and now we have for the first time a way to — not for a 100%— but for a…